The activation of the PI3-K/Akt/mTOR signaling pathway is well established in various types of B cell NHLs, such as DLBCL, MCL, chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL) [3]. This evidence concerns the gene PIK3CD and B-cell non-Hodgkin lymphoma.